3D In Vitro Models: Novel Insights into Idiopathic Pulmonary Fibrosis Pathophysiology and Drug Screening
Open Access
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive and often lethal interstitial lung disease of unknown aetiology. IPF is characterised by myofibroblast activation, tissue stiffening, and alveolar epithelium injury. As current IPF treatments fail to halt disease progression or induce regeneration, there is a pressing need for the development of novel therapeutic targets. In this regard, tri-dimensional (3D) models have rapidly emerged as powerful platforms for disease modelling, drug screening and discovery. In this review, we will touch on how 3D in vitro models such as hydrogels, precision-cut lung slices, and, more recently, lung organoids and lung-on-chip devices have been generated and/or modified to reveal distinct cellular and molecular signalling pathways activated during fibrotic processes. Markedly, we will address how these platforms could provide a better understanding of fibrosis pathophysiology and uncover effective treatment strategies for IPF patients.Keywords
Funding Information
- German Research Foundation (SFB 1021 C05)
This publication has 66 references indexed in Scilit:
- Hydrogel: Preparation, characterization, and applications: A reviewJournal of Advanced Research, 2015
- Pathogenesis of Idiopathic Pulmonary FibrosisAnnual Review of Pathology: Mechanisms of Disease, 2014
- Animal Models of Fibrotic Lung DiseaseAmerican Journal of Respiratory Cell and Molecular Biology, 2013
- Type 2 alveolar cells are stem cells in adult lungJournal of Clinical Investigation, 2013
- Revisiting lab-on-a-chip technology for drug discoveryNature Reviews Drug Discovery, 2012
- Idiopathic Pulmonary Fibrosis: Diagnosis and EpidemiologyClinics in Chest Medicine, 2012
- Feedback amplification of fibrosis through matrix stiffening and COX-2 suppressionJournal of Cell Biology, 2010
- Preparation of Hydrogel Substrates with Tunable Mechanical PropertiesCurrent Protocols in Cell Biology, 2010
- Defective Histone Acetylation Is Responsible for the Diminished Expression of Cyclooxygenase 2 in Idiopathic Pulmonary FibrosisMolecular and Cellular Biology, 2009
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?The International Journal of Biochemistry & Cell Biology, 2008